DB18139InvestigationalGene Therapies
SBT101 is a non-replicating recombinant adeno-associated virus serotype 9 (AAV9) gene therapy vector containing the human adenosine triphosphate (ATP)-binding cassette (ABC) sub-family D member 1 (ABCD1) gene.
- Code names
- SBT-101
Resolves to
Compound
What you can answer from here — as of September 25, 2025
Which companies are running trials of SBT101, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account